Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Swertisin | 6991-10-2 | 5 MG
SDP

Catalog No. 5000420310
Encompass_Preferred

Swertisin is an oral adenosine A1 receptor antagonist and an SGLT2 inhibitor. It exhibits anti-diabetic and antioxidant properties, inhibits HBV, and improves cognitive and memory impairments in mice.

  • Acts as an oral adenosine A1 receptor antagonist and SGLT2 inhibitor
  • Exhibits anti-diabetic and antioxidant properties
  • Inhibits HBV
  • Improves cognitive and memory impairments
  • Inhibits glucose uptake in HEK293 cells
  • Suppresses HBsAg, HBeAg, and HBV DNA levels
  • Reduces SGLT2 expression and lowers blood sugar in vivo

Catalog No. 50-004-20310 Supplier Medchemexpress LLC Supplier No. HYN21895MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Swertisin is an oral adenosine A1 receptor antagonist and an SGLT2 inhibitor. It exhibits anti-diabetic and antioxidant properties, inhibits HBV, and improves cognitive and memory impairments in mice.

  • Acts as an oral adenosine A1 receptor antagonist and SGLT2 inhibitor
  • Exhibits anti-diabetic and antioxidant properties
  • Inhibits HBV
  • Improves cognitive and memory impairments
  • Inhibits glucose uptake in HEK293 cells
  • Suppresses HBsAg, HBeAg, and HBV DNA levels
  • Reduces SGLT2 expression and lowers blood sugar in vivo

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.